U.S. officials have granted full approval to a closely watched Alzheimer’s drug for patients with early stages of the disease. The Food and Drug Administration decision clears the way for Medicare and other insurers to begin paying for the drug called Leqembi.
Subscribe to FOX 5 NY: [ Ссылка ]
Watch FOX 5 NY Live: [ Ссылка ]
FOX 5 NY delivers breaking news, live events, investigations, politics, entertainment, business news and local stories from New York City and across the nation.
Watch more FOX 5 NY on YouTube:
Black Entrepreneurs: [ Ссылка ]
STREET SOLDIERS with LISA EVERS: [ Ссылка ]
A.I. ALL IN: [ Ссылка ]
Finding Faith: [ Ссылка ]
The Big Idea: [ Ссылка ]
Download the FOX 5 NY News app: [ Ссылка ]
Download the FOX 5 NY Weather app: [ Ссылка ]
Follow FOX 5 NY on Facebook: [ Ссылка ]
Follow FOX 5 NY on Twitter: [ Ссылка ]
Follow FOX 5 NY on Instagram: [ Ссылка ]
Subscribe to the Good Day NY Morning Brief newsletter: [ Ссылка ]
